Financials HeartBeam, Inc.

Equities

BEAT

US42238H1086

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 20:00:45 16/05/2024 BST 5-day change 1st Jan Change
2.145 USD -0.23% Intraday chart for HeartBeam, Inc. +6.92% -8.55%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 24.05 39.06 61.87 56.74 - -
Enterprise Value (EV) 1 24.05 39.06 61.87 56.74 56.74 56.74
P/E ratio -2.99 x -3.07 x -3.26 x -2.95 x -3.41 x -4.13 x
Yield - - - - - -
Capitalization / Revenue - - - - 43,648,360 x 4,651,055 x
EV / Revenue - - - - 43,648,360 x 4,651,055 x
EV / EBITDA - - - - - -
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) 7,810 8,005 26,329 26,392 - -
Reference price 2 3.080 4.880 2.350 2.150 2.150 2.150
Announcement Date 24/03/22 16/03/23 20/03/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales - - - - 1.3 12.2
EBITDA - - - - - -
EBIT - -13.03 -15.31 - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) - -12.96 -14.64 - - -
Net income -4.428 -12.96 -14.64 - - -
Net margin - - - - - -
EPS 1 -1.030 -1.590 -0.7200 -0.7300 -0.6300 -0.5200
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 24/03/22 16/03/23 20/03/24 - - -
1USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 - - - - - - - - - 5.25 6.75 0.1 0.2
EBITDA - - - - - - - - - - - - -
EBIT -3.535 -3.61 -3.739 -4.156 -3.312 -3.737 -4.109 -4.784 - - - - -
Operating Margin - - - - - - - - - - - - -
Earnings before Tax (EBT) -3.525 -3.579 -3.712 -4.136 -3.154 -3.47 -3.879 -4.606 - - - - -
Net income -3.525 -3.579 -3.712 -4.136 -3.154 -3.47 -3.879 -4.606 - - - - -
Net margin - - - - - - - - - - - - -
EPS 2 -0.4300 -0.4400 -0.4500 -0.5000 -0.1600 -0.1300 -0.1300 -0.1700 -0.1800 -0.1800 - -0.1700 -0.1700
Dividend per Share - - - - - - - - - - - - -
Announcement Date 11/08/22 10/11/22 16/03/23 11/05/23 10/08/23 14/11/23 20/03/24 09/05/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2025 2026
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 24/03/22 16/03/23 20/03/24 - -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
2.15 USD
Average target price
5 USD
Spread / Average Target
+132.56%
Consensus
  1. Stock Market
  2. Equities
  3. BEAT Stock
  4. Financials HeartBeam, Inc.